Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,378.19
2,263.58
2,354.55
2,237.22
2,289.46
2,122.35
1,814.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,378.19
2,263.58
2,354.55
2,237.22
2,289.46
2,122.35
1,814.25
Raw Material Cost
3.85
0.00
0.00
5.67
23.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
307.66
225.51
187.19
187.96
166.14
156.54
275.46
Selling and Distribution Expenses
658.66
236.67
249.75
227.30
182.83
181.72
103.44
Other Expenses
14.43
-22.35
-13.52
-1.09
3.39
-13.02
-19.24
Total Expenditure (Excl Depreciation)
1,114.51
238.67
301.75
410.08
405.91
208.00
186.47
Operating Profit (PBDIT) excl Other Income
1263.7
2024.9
2052.8
1827.1000000000001
1883.6000000000001
1914.3000000000002
1627.8
Other Income
48.33
75.43
79.44
54.61
28.37
35.95
-15.98
Operating Profit (PBDIT)
1,611.70
1,367.87
1,571.59
983.17
1,482.08
1,654.41
2,631.12
Interest
307.66
225.51
187.19
187.96
166.14
156.54
275.46
Exceptional Items
24.01
188.46
315.69
-559.47
-51.74
227.14
129.68
Gross Profit (PBDT)
2,374.34
0.00
0.00
2,231.55
2,266.47
0.00
0.00
Depreciation
3.85
0.00
0.00
5.67
23.00
23.06
23.92
Profit Before Tax
1,324.19
1,330.81
1,700.09
230.06
1,241.20
1,701.95
2,461.42
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
770.95
858.98
1,134.83
42.83
619.73
975.04
2,348.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
770.95
858.98
1,134.83
42.83
619.73
975.04
2,348.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
553.25
471.83
565.25
187.23
621.47
726.91
112.88
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,324.19
1,330.81
1,700.09
230.06
1,241.20
1,701.95
2,461.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,476.90
6,946.58
6,526.50
5,628.15
5,776.59
4,818.78
6,105.56
Earnings per share (EPS)
1.78
1.91
2.53
0.1
1.49
2.6
6.42
Diluted Earnings per share
1.78
1.91
2.53
0.1
1.49
2.6
6.42
Operating Profit Margin (Excl OI)
65.58%
57.1%
63.37%
41.25%
62.49%
75.17%
144.59%
Gross Profit Margin
55.84%
58.79%
72.2%
10.54%
55.22%
81.28%
136.99%
PAT Margin
32.42%
37.95%
48.2%
1.91%
27.07%
45.94%
129.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 5.06% vs -3.86% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -0.50% vs -21.72% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 20.97% vs -13.39% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 36.45% vs 20.46% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Royalty Pharma Plc With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
2,378.19
14,293.20
-11,915.01
-83.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,378.19
14,293.20
-11,915.01
-83.36%
Raw Material Cost
3.85
8,644.70
-8,640.85
-99.96%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
307.66
478.20
-170.54
-35.66%
Selling and Distribution Expenses
658.66
3,533.50
-2,874.84
-81.36%
Other Expenses
14.43
47.43
-33.00
-69.58%
Total Expenditure (Excl Depreciation)
1,114.51
13,130.70
-12,016.19
-91.51%
Operating Profit (PBDIT) excl Other Income
1,263.68
1,162.50
101.18
8.70%
Other Income
48.33
97.90
-49.57
-50.63%
Operating Profit (PBDIT)
1,611.70
3,984.80
-2,373.10
-59.55%
Interest
307.66
478.20
-170.54
-35.66%
Exceptional Items
24.01
-4,447.20
4,471.21
100.54%
Gross Profit (PBDT)
2,374.34
5,648.50
-3,274.16
-57.97%
Depreciation
3.85
2,724.40
-2,720.55
-99.86%
Profit Before Tax
1,324.19
-3,665.00
4,989.19
136.13%
Tax
0.00
-150.10
150.10
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
770.95
-3,514.90
4,285.85
121.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
770.95
-3,514.90
4,285.85
121.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
553.25
0.00
553.25
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,324.19
-3,514.90
4,839.09
137.67%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,476.90
14,711.30
-8,234.40
-55.97%
Earnings per share (EPS)
1.78
-3.00
4.78
159.33%
Diluted Earnings per share
1.78
-3.00
4.78
159.33%
Operating Profit Margin (Excl OI)
65.58%
8.13%
0.00
57.45%
Gross Profit Margin
55.84%
-6.58%
0.00
62.42%
PAT Margin
32.42%
-24.59%
0.00
57.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 237.82 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.06% vs -3.86% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 132.42 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.50% vs -21.72% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 156.34 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.97% vs -13.39% in Dec 2024
Annual - Interest
Interest 30.77 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 36.45% vs 20.46% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 65.58%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
